Categorisation of people into low, moderate and high CVD risk is anachronism and should be abandoned, see joint WHF and WSO statement in Lancet lnkd.in/gi73Vjtv
Do not miss the opportunity to register for the exiting international virtual meeting
The ICNE 2022 conference is due to start in just over a week, and we are really looking forward to e-meeting you there!
Please check out the website lnkd.in/g3nW3zmd
The newest issue of Neuroepidemiology 2022, Vol. 56, No. 2 is now released!
➡️ ow.ly/zeHW50IMqC1
Topics in this issue include: #Glioblastoma #ALS #FebrileSeizures #Epilepsy #PhysicalActivity #CognitiveFunction #Gender and #Race
The newest issue of Neuroepidemiology 2022, Vol. 56, No. 2 is now released!
ow.ly/zeHW50IMqC1
Topics in this issue include: #Glioblastoma #ALS #FebrileSeizures #Epilepsy #PhysicalActivity #CognitiveFunction #Gender and #Race
National Institute of Stroke and Applied Neurosciences of Auckland University of Technology, New Zealand is one of the winners of the WHO Western Pacific Innovation Challenge (April 2022). lnkd.in/gnaRkZbb
World Stroke Oorganization #digital #digital #webinar #webinar # # # # # webinar on digital technologies for primary and secondary stroke prevention lnkd.in/dKHuz67v
Tangible digital solutions for effective primary and secondary stroke/CVD and other major NCDs that share common risk factors with stroke/CVD are released by The Lancet Regional Health. Translations of the tools #in any languages i…lnkd.in/dH5wS63w lnkd.in/dBZEJpkv
National Institute for Stroke & Applied Neurosciences, Auckland University of Technology (New Zealand) research activities and output at glance lnkd.in/geMfxJTf
High CVD risk prevention strategies and failure to reduce stroke and CVD burden across the globe. Valery Feigin interview for VJNeurology
#stroke #prevention lnkd.in/gFjBvsXY
Problems and solutions for primary stroke prevention, and polypill for stroke prevention. For the whole series of interviews, see #stroke #prevention #newapproach lnkd.in/geC3nkD2